Clinical Trial

Phase 2 Trial Of S-531011 With RadScopal In Previously Treated Metastatic Colorectal Cancer

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To learn if the experimental drug S-531011 plus RadScopalTM radiation therapy can help to control previously treated metastatic colorectal cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-17.
Trial Details
NCT Number NCT07720115
Lead Sponsor M.D. Anderson Cancer Center
Conditions Phase II, S-531011, RadScopal, Metastatic Colorectal Cancer
Enrollment 30 participants
Start Date 2027-01-07
Primary Completion 2029-01-01 (estimated)
Study Completion 2031-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-24